{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:01:17Z","timestamp":1780725677667,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"DOI":"10.7759\/cureus.110331","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:11:08Z","timestamp":1780722668000},"source":"Crossref","is-referenced-by-count":0,"title":["Sino-Cranial Aspergillosis in an ABO-Incompatible Renal Transplant Recipient Following a \"March of Infections\""],"prefix":"10.7759","author":[{"given":"Jyoti Prakash","family":"Panda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Langote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshad","family":"Nikte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxman","family":"Jessani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.11.039","article-title":"Fungal disease of the nose and paranasal sinuses","volume":"129","author":"Thompson GR III","year":"2012","unstructured":"Thompson GR III, Patterson TF. Fungal disease of the nose and paranasal sinuses. J Allergy Clin Immunol. 2012, 129:321-6. 10.1016\/j.jaci.2011.11.039","journal-title":"J Allergy Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/1793-5482.144188","article-title":"Invasive aspergillus sinusitis with orbitocranial extension","volume":"12","author":"Baeesa SS","year":"2017","unstructured":"Baeesa SS, Bokhari RF, Alghamdi KB, Alem HB, Al-Maghrabi JA, Madani TA. Invasive aspergillus sinusitis with orbitocranial extension. Asian J Neurosurg. 2017, 12:172-9. 10.4103\/1793-5482.144188","journal-title":"Asian J Neurosurg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05958-3","article-title":"Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response","volume":"21","author":"Neofytos D","year":"2021","unstructured":"Neofytos D, Garcia-Vidal C, Lamoth F, Lichtenstern C, Perrella A, Vehreschild JJ. Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response. BMC Infect Dis. 2021, 21:296. 10.1186\/s12879-021-05958-3","journal-title":"BMC Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman JA","year":"2007","unstructured":"Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007, 357:2601-14. 10.1056\/NEJMra064928","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \u201cnet state of immunosuppression\u201d","volume":"73","author":"Roberts MB","year":"2021","unstructured":"Roberts MB, Fishman JA. Immunosuppressive agents and infectious risk in transplantation: managing the \u201cnet state of immunosuppression\u201d. Clin Infect Dis. 2021, 73:1302-17. 10.1093\/cid\/ciaa1189","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw017","article-title":"The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation","volume":"31","author":"Lee J","year":"2016","unstructured":"Lee J, Lee JG, Kim S, et al.. The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation. Nephrol Dial Transplant. 2016, 31:1013-21. 10.1093\/ndt\/gfw017","journal-title":"Nephrol Dial Transplant"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00234","article-title":"ABO-incompatible kidney transplantation","volume":"8","author":"Morath C","year":"2017","unstructured":"Morath C, Zeier M, D\u00f6hler B, Opelz G, S\u00fcsal C. ABO-incompatible kidney transplantation. Front Immunol. 2017, 8:234. 10.3389\/fimmu.2017.00234","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16248","article-title":"Risk factors for the development of invasive aspergillosis after kidney transplantation: systematic review and meta-analysis","volume":"21","author":"P\u00e9rez-Jacoiste As\u00edn MA","year":"2021","unstructured":"P\u00e9rez-Jacoiste As\u00edn MA, L\u00f3pez-Medrano F, Fern\u00e1ndez-Ruiz M, et al.. Risk factors for the development of invasive aspergillosis after kidney transplantation: systematic review and meta-analysis. Am J Transplant. 2021, 21:703-16. 10.1111\/ajt.16248","journal-title":"Am J Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson TF","year":"2016","unstructured":"Patterson TF, Thompson GR III, Denning DW, et al.. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016, 63:1-60. 10.1093\/cid\/ciw326","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac927","article-title":"Risk factors and outcomes of invasive aspergillosis in kidney transplant recipients: a case-control study of United States Renal Data System data","volume":"76","author":"Friedman DZ","year":"2023","unstructured":"Friedman DZ, Johnson BK, Beam E, Kremers WK, Vergidis P. Risk factors and outcomes of invasive aspergillosis in kidney transplant recipients: a case-control study of United States Renal Data System data. Clin Infect Dis. 2023, 76:1431-9. 10.1093\/cid\/ciac927","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly JP","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, et al.. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020, 71:1367-76. 10.1093\/cid\/ciz1008","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13451","article-title":"Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: a comparison of galactomannan, Mannan and \u03b2-1,3-D-Gucan testing from serum and cerebrospinal fluid","volume":"65","author":"Forster J","year":"2022","unstructured":"Forster J, Hoenigl M, Suerbaum S, Wagener J, Dichtl K. Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: a comparison of galactomannan, Mannan and \u03b2-1,3-D-Gucan testing from serum and cerebrospinal fluid. Mycoses. 2022, 65:709-14. 10.1111\/myc.13451","journal-title":"Mycoses"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2024.05.013","article-title":"Cerebrospinal fluid galactomannan detection for the diagnosis of central nervous system aspergillosis: a diagnostic test accuracy systematic review and meta-analysis","volume":"30","author":"Komorowski AS","year":"2024","unstructured":"Komorowski AS, Hall CW, Atwal S, et al.. Cerebrospinal fluid galactomannan detection for the diagnosis of central nervous system aspergillosis: a diagnostic test accuracy systematic review and meta-analysis. Clin Microbiol Infect. 2024, 30:1244-53. 10.1016\/j.cmi.2024.05.013","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad274","article-title":"S-D-glucan assay in the cerebrospinal fluid for the diagnosis of non-cryptococcal fungal infection of the central nervous system: a retrospective multicentric analysis and a comprehensive review of the literature","volume":"77","author":"Bigot J","year":"2023","unstructured":"Bigot J, Leroy J, Chouaki T, et al.. S-D-glucan assay in the cerebrospinal fluid for the diagnosis of non-cryptococcal fungal infection of the central nervous system: a retrospective multicentric analysis and a comprehensive review of the literature. Clin Infect Dis. 2023, 77:711-20. 10.1093\/cid\/ciad274","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jof7010014","article-title":"Specificity influences in (1\u21923)-\u03b2-D-glucan-supported diagnosis of invasive fungal disease","volume":"7","author":"Finkelman MA","year":"2020","unstructured":"Finkelman MA. Specificity influences in (1\u21923)-\u03b2-D-glucan-supported diagnosis of invasive fungal disease. J Fungi (Basel). 2020, 7:14. 10.3390\/jof7010014","journal-title":"J Fungi (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122739","article-title":"The effect of voriconazole on tacrolimus in kidney transplantation recipients: a real-world study","volume":"14","author":"Zhao YC","year":"2022","unstructured":"Zhao YC, Xiao CL, Hou JJ, et al.. The effect of voriconazole on tacrolimus in kidney transplantation recipients: a real-world study. Pharmaceutics. 2022, 14:2739. 10.3390\/pharmaceutics14122739","journal-title":"Pharmaceutics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14232","article-title":"Determinants of the magnitude of interaction between tacrolimus and voriconazole\/posaconazole in solid organ recipients","volume":"17","author":"Vanhove T","year":"2017","unstructured":"Vanhove T, Bouwsma H, Hilbrands L, et al.. Determinants of the magnitude of interaction between tacrolimus and voriconazole\/posaconazole in solid organ recipients. Am J Transplant. 2017, 17:2372-80. 10.1111\/ajt.14232","journal-title":"Am J Transplant"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2022.10.005","article-title":"Clinical practice guideline for the therapeutic drug monitoring of voriconazole in non-Asian and Asian adult patients: consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"44","author":"Takesue Y","year":"2022","unstructured":"Takesue Y, Hanai Y, Oda K, et al.. Clinical practice guideline for the therapeutic drug monitoring of voriconazole in non-Asian and Asian adult patients: consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Clin Ther. 2022, 44:1604-23. 10.1016\/j.clinthera.2022.10.005","journal-title":"Clin Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499765-sino-cranial-aspergillosis-in-an-abo-incompatible-renal-transplant-recipient-following-a-march-of-infections","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:11:08Z","timestamp":1780722668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499765-sino-cranial-aspergillosis-in-an-abo-incompatible-renal-transplant-recipient-following-a-march-of-infections"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.110331","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}